Millennium Management’s Celgene Corporation Contingent Value Rights CELGZ Stock Holding History

Millennium Management’s Portfolio CELGZ Stock Details CELGZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-127,224	Closed	-$132K	–	4038
2016 Q3	$132K	Hold	127,224	–	–	﹤0.01%	3081
2016 Q2	$186K	Hold	127,224	–	–	﹤0.01%	2917
2016 Q1	$167K	Hold	127,224	–	–	﹤0.01%	3001
2015 Q4	$153K	Sell	127,224 -43,366	-25%	-$57.7K	﹤0.01%	3175
2015 Q3	$275K	Sell	170,590 -84,660	-33%	-$163K	﹤0.01%	2960
2015 Q2	$531K	Sell	255,250 -62,141	-20%	-$159K	﹤0.01%	2613
2015 Q1	$943K	Sell	317,391 -5,000	-2%	-$15.8K	﹤0.01%	2346
2014 Q4	$1.02M	Sell	322,391 -18,627	-5%	-$62.8K	﹤0.01%	2480
2014 Q3	$1.16M	Hold	341,018	–	–	﹤0.01%	2209
2014 Q2	$887K	Sell	341,018 -32,300	-9%	-$89.4K	﹤0.01%	2266
2014 Q1	$1.05M	Sell	373,318 -66,828	-15%	-$202K	﹤0.01%	2193
2013 Q4	$1.2M	Sell	440,146 -354,932	-45%	-$996K	﹤0.01%	2155
2013 Q3	$6.39M	Buy	795,078 +316,720	+66%	+$2.44M	0.02%	971
2013 Q2	$3.5M	Buy	+478,358	New	+$3.47M	0.01%	1243

Other funds holding CELGZ

Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return

Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return

FCG Advisors Chatham, New Jersey $425M AUM 12.09% 1-Year Est. Return

UAS

United Asset Strategies Garden City, New York $1.41B AUM 27.73% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

MSTVIM

Messner & Smith Theme Value Investment Management San Diego, California $60.3M AUM 16.8% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Millennium Management's CELGZ Position: Q4 2016 in Review

Millennium Management sold out of Celgene Corporation Contingent Value Rights (CELGZ) in Q4 2016, closing a stake of 127,224 shares — an estimated $132K sold.

Millennium Management first reported a position in CELGZ in Q2 2013 and held it in 14 quarters. The position peaked at $6.39M in Q3 2013. 26 funds tracked by Wall St. Rank hold CELGZ as of Q4 2016.

Millennium Management reported no remaining Celgene Corporation Contingent Value Rights position as of Q4 2016 after selling out during the quarter.
Millennium Management sold 127,224 Celgene Corporation Contingent Value Rights shares in Q4 2016, an estimated $132K.
Millennium Management first reported a position in Celgene Corporation Contingent Value Rights in Q2 2013 and held it in 14 quarters.
Millennium Management's Celgene Corporation Contingent Value Rights position peaked at $6.39M in Q3 2013.
26 funds tracked by Wall St. Rank held Celgene Corporation Contingent Value Rights as of Q4 2016.

Based on Millennium Management's 13F filing for Q4 2016, filed 14 Feb 2017.